Form 4: MAIA Biotechnology Director Receives Stock Grant
Insider Transaction (Form 4)
Stan Smith, a Director of MAIA Biotechnology, Inc., received 38,871 shares of common stock on September 30, 2026.
Summary
- Grant/award: acquired 38,871 Stock Options on September 30, 2026; holds 38,871 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Stan Smith — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Grant/award | Stock Options | 38,871 | — | — | 38,871 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Grant/award (38,871 shares) |
Keywords
insider transaction, Form 4, MAIA, MAIA Biotechnology, Inc., neutral, Stan Smith
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.